Family Role in Care of Patients With Neurological Conditions: International Neuroscience Nursing Research Symposium Proceedings.

ABSTRACT: BACKGROUND: Discussions during the 2022 International Neuroscience Nursing Research Symposium highlighted the impact of family in the care of neuroscience patients. This sparked conversations about the need for understanding global differences in family involvement in the care of patients with neurological conditions. METHODS: Neuroscience nurses from Germany, India, Japan, Kenya, Singapore, Saudi Arabia, the United States, and Vietnam collaborated to provide a short summary of family involvement in caring for patients with neurological conditions in their respective countries. RESULTS: Family roles for neuroscience patients vary across the globe. Caring for neuroscience patients can be challenging. Family involvement in treatment decisions and patient care can be affected by sociocultural beliefs and practices, economic factors, hospital policies, manifestation of the disease, and long-term care requirements. CONCLUSION: Understanding the geographic, cultural, and sociopolitical implications of family involvement in care is of benefit to neuroscience nurses.

Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.

The World Health Organization states that only a reduction in tobacco use would lower the number of deaths from cancer. It is possible to decrease the number of deaths by means of prevention and/or smoking cessation. Smoking cessation therapy includes both psychological support and pharmacological treatment: Nicotine Replacement Therapy (NRT), Bupropion Sustained-Release, and Varenicline. The aim of the Smoking Cessation Center of Parma is to provide instruments, methodologies and individual therapies for achieving abstinence or a decrease in tobacco use. The program of the Smoking Cessation Center consists in eight meetings. During the first meeting the smoker undergoes a medical check up, and smoking history, exhaled single breath CO and dependence of nicotine are recorded and a personal therapy is planned. During each follow-up visit (after 15 days and then at 1,2,3,6,9 and 12-month intervals) the compliance of the patient to the treatment and abstinence symptoms are assessed. Since 2000, we achieved tobacco abstinence in 28% of patients. Combined treatment (Bupropion/NRT) provided a higher percentage of success (39.9%).